MedTrace Logo

Peanut Consumption on Cognitive, Weight, and Inflammation

NCT06127511 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2025-04-03

No results posted yet for this study

Summary

A multi-school, two-arm parallel cluster-randomized controlled trial will be conducted in 200 healthy young adolescents from Barcelona (Spain) to evaluate the effect of peanut consumption on cognitive performance, weight management and inflammation. Schools willing to participate will be randomly assigned to either the intervention or the control group. After the recruitment, the participants will follow a peanut-free diet for two weeks. Both arms will receive a multidimensional educational intervention designed by the Gasol Foundation to promote healthy dietary habits based on Mediterranean diet recommendations, along with exercise performance, healthy sleeping habits and emotional knowledge. Half of the participants (intervention group) will consume 25 g of whole skin roasted peanuts as a daily snack to be incorporated into their diet for six months.

Conditions

  • Cognitive Performance
  • Inflammation
  • Weight Change, Body
  • Adolescents

Interventions

OTHER

Food (peanut)

After the recruitment, the participants will follow a peanut-free diet for two weeks.

Sponsors & Collaborators

  • Gasol Foundation

    collaborator UNKNOWN

  • Universitat Oberta de Catalunya

    collaborator OTHER

  • Institut d'Investigacions Biomèdiques August Pi i Sunyer

    collaborator OTHER

  • University of Barcelona

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-29
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06127511 on ClinicalTrials.gov